SMALES KELLY sold 2.7% of their position (2.19K shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $7.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/3/2024ACC: 0001209191-24-000530
-2.19K
Net shares
Net seller
$7.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.19K
Price / share
$3.61
Trade value
$7.90K
% of position
2.7%
1/2/2024
79.63K→77.45K
Total
Net shares
−2.19K
Net value
-$7.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2024 | S · Sale | −2.19K | $3.61 | $7.90K | 2.7% | 79.63K | 77.45K |
| Total | −2.19K | -$7.90K | ||||||
Derivative Transactions0
No derivative transactions reported